Carey Oconnor Kolaja
Director, Revance Therapeutics, Inc.
Companies
- Revance Therapeutics, Inc.Board member Mar 2, 2021 to Feb 6, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Revance Therapeutics, Inc.0 shares2Feb 6, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 6, 2025Returned to company 15,000 shares of Revance Therapeutics, Inc.2
- Feb 4, 2025U 16,561 shares at $3.65 of Revance Therapeutics, Inc.2
- May 1, 2024Granted 15,000 shares of Revance Therapeutics, Inc.3
- Jun 15, 2023Sold 2,500 shares at $28.24 of Revance Therapeutics, Inc.4
- Jun 15, 2023Exercised options 2,500 shares at $18.12 of Revance Therapeutics, Inc.4
- May 3, 2023Granted 3,534 shares of Revance Therapeutics, Inc.5
- May 4, 2022Granted 6,059 shares of Revance Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 3, 2024
- 4SEC EDGARForm 4 filed Jun 20, 2023
- 5SEC EDGARForm 4 filed May 5, 2023
- 6SEC EDGARForm 4 filed May 6, 2022